Company Overview and News

 
Orbital’s Cygnus To Demo Commercial Capabilities

14h aviationweek
HOUSTON—Successfully berthed to the International Space Station’s (ISS) U.S. segment Unity module early May 24, Orbital ATK’s Cygnus resupply capsule is poised to break ground on new activities that the private sector might shoulder in low Earth orbit as NASA plans to transition its human exploration focus to deep ...

 
55 Communication Satellites in Orbit for the Iridium NEXT Constellation

15h asdnews
The sixth batch of Iridium® NEXT satellites built by Thales Alenia Space has been successfully launched by SpaceX from Vandenberg Air Force Base in California. The success of this sixth launch for the Iridium® NEXT program further solidifies the company’s reputation for excelled expertise as prime contractor for sophisticated satellite communications (SATCOM) systems.

 
Orbital ATK Successfully Launches 9th Cargo Delivery Mission to the ISS for NASA

2018-05-22 asdnews
Orbital ATK (NYSE:OA), a global leader in aerospace and defense technologies, successfully launched the company’s AntaresTM rocket carrying its CygnusTM spacecraft today at 4:44 a.m. EDT from the Mid-Atlantic Regional Spaceport Pad 0A on Wallops Island, Virginia, at NASA’s Wallops Flight Facility. The launch marks Orbital ATK’s ninth cargo mission for NASA.

 
Cement, extreme cold experiments head to space aboard Cygnus cargo ship

2018-05-21 yahoo
Tampa (AFP) - Food for astronauts, new space gardening gear and experiments to test extreme cold and how cement forms in weightlessness blasted off Monday to the International Space Station aboard Orbital ATK's unmanned Cygnus spacecraft.

 
Orbital’s Cygnus Heads For May 24 Space Station Berthing

2018-05-21 aviationweek
Orbital ATK’s ninth NASA-contracted Cygnus resupply mission maneuvered toward a May 24 rendezvous and berthing at the International Space Station (ISS), following launch from NASA’s Wallops Island, Va., flight facility carrying 7,400 lb. of supplies, science experiments and technology ...

 
NASA shipper Orbital ATK launches space station supplies

2018-05-21 nzherald.co.nz
CAPE CANAVERAL, Fla. (AP) — One of NASA's prime shippers, Orbital ATK, has launched a fresh load of supplies to the International Space Station.

 
Orbital ATK Set to Launch 9th Cargo Resupply Mission to the ISS

2018-05-21 asdnews
Orbital ATK (NYSE: OA), a global leader in aerospace and defense technologies, today announced it is set to launch the company’s AntaresTM rocket carrying its CygnusTM cargo spacecraft to the International Space Station for NASA. Pending completion of final vehicle testing and acceptable local weather conditions, the launch will take place Monday, May 21 with lift-off scheduled for 4:39 a.m. EDT from the Mid-Atlantic Regional Spaceport Pad 0A on Wallops Island, Virginia, at NASA’s Wallops Flight Facility.

 
Cement, extreme cold experiments to launch on Orbital cargo ship

2018-05-21 yahoo
Tampa (AFP) - Food for astronauts, new space gardening gear and an experiment to test how cement forms in weightlessness are poised to launch Monday to the International Space Station aboard Orbital ATK's unmanned Cygnus spacecraft.

 
Orbital freighter set to carry cement, extreme cold experiments, and food, to ISS

2018-05-21 japantimes.co.jp
MIAMI – Food for astronauts, new space gardening gear and an experiment on how cement forms in microgravity are poised to launch Monday to the International Space Station aboard Orbital ATK’s unmanned Cygnus spacecraft.

 
Orbital ISS Cargo Mission Launch Moves To May 21

2018-05-19 aviationweek
The launch of Orbital ATK’s ninth NASA-contracted re-supply mission to the International Space Station from Wallops Island Flight Facility on Virginia’s eastern shore has been re-set to May 21 at 4:39 a.m. EDT, a day’s delay, to accommodate additional pre-launch inspections and an improved weather outlook. A successful liftoff of the Antares rocket with an enhanced Cygnus cargo capsule and 7,400 lb.

 
The Week In Defense, May 17-24, 2018

2018-05-16 aviationweek
United Launch Alliance (ULA) has not yet announced whether it will stick with original plans to buy Blue Origin BE-4 engines to power the first stage of its Vulcan rocket or switch to Aerojet Rocketdyne’s AR1. But when the Vulcan debuts in 2020, its Centaur upper stage will be powered by Aerojet’s RL10, a version of which also was chosen by competitor Orbital ATK for the upper stage of its planned Omega rocket (formerly known as the Next Generation Launch System).

 
Northrop Grumman: Buy This Growing Military Company For Total Return

2018-05-16 seekingalpha
Northrop Grumman's total return over-performed the Dow average for my 52.0-month test period by 143.48% which is fantastic.

 
Northrop Grumman (NOC) Approves 9% Increase in Dividend

2018-05-16 zacks
Northrop Grumman Corporation (NOC - Free Report) announced that its board of directors has approved a 9% hike in its quarterly common stock dividend. This has taken the annualized payout to $4.80 per share. The new quarterly dividend of $1.20 per share is up by a dime from the earlier quarterly dividend. The hiked dividend will be paid on Jun 20, 2018 to shareholders of record at the close of business on Jun 4.

 
Orbital ATK and IMI Systems Partner to Jointly Introduce New Weapons Technology for the US

2018-05-11 asdnews
Orbital ATK (NYSE: OA), a global leader in aerospace and defense technologies, and IMI Systems Ltd. have announced a teaming agreement in which Orbital ATK will produce and supply a U.S. version of IMI’s 500-lb Multi-Purpose Rigid Bomb (MPR500) and the MPR family of bombs for the United States.

 
Precision approach [SOFEXD1]

2018-05-07 janes
Intelsat General, a wholly owned subsidiary of Intelsat (Hall 6, Stand A602), has announced that it is part of a team of companies awarded a new task order by the Federal Aviation Administration (FAA) to develop and operate a satellite payload to aid aircraft navigation, in particular precision approaches to airports without dependence on ground-based infrastructure.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

16h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

17h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

CUSIP: 68557N103